Work

Ramucirumab plus merestinib in previously treated metastatic colorectal cancer: safety, pharmacokinetic, and preliminary efficacy findings from a Phase 1 study

Year: 2019

Type: article

Study design: Clinical Trial

Source: Annals of Oncology

DOI: 10.1093/annonc/mdz157.007

Authors: M. Saleh, P. Cassier, L. Eberst, G. Naik, V. Morris II, S. Pant, C. Terret, L. Gao, A. Long, H. Mao, S. McNeely, R. Carlesi, S. Fu

Institutions: Georgia Cancer Specialists, Centre Léon Bérard, University of Alabama at Birmingham, O'Neal Comprehensive Cancer Center, The University of Texas MD Anderson Cancer Center, Eli Lilly (United States), Eli Lilly (Italy)

Language: English

Topic: Colorectal Cancer Treatments and Studies

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W2959428144

FWCI: 0.091

Cites:

Cited by: 1

Related to: 10